# Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism

> **NCT05823012** · PHASE2 · COMPLETED · sponsor: **Xeris Pharmaceuticals** · enrollment: 46 (actual)

## Conditions studied

- Hypothyroidism

## Interventions

- **DRUG:** levothyroxine sodium

## Key facts

- **NCT ID:** NCT05823012
- **Lead sponsor:** Xeris Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-15
- **Primary completion:** 2024-02-22
- **Final completion:** 2024-02-22
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05823012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05823012, "Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05823012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*